Rapp–Hodgkin syndrome

From WikiMD's Wellness Encyclopedia

Autosomal_dominant_-_en.svg

Rapp–Hodgkin syndrome (RHS) is a rare genetic disorder characterized by a combination of ectodermal dysplasia, cleft lip and palate, and other anomalies. It is named after the researchers Robert S. Rapp and Peter J. Hodgkin, who first described the syndrome.

Presentation[edit | edit source]

Individuals with Rapp–Hodgkin syndrome typically present with a variety of symptoms, including:

Genetics[edit | edit source]

Rapp–Hodgkin syndrome is inherited in an autosomal dominant manner. Mutations in the TP63 gene, which plays a crucial role in the development of ectodermal tissues, are responsible for the condition. The TP63 gene is also implicated in other syndromes such as Ectrodactyly-Ectodermal Dysplasia-Clefting syndrome (EEC) and Ankyloblepharon-Ectodermal Defects-Cleft Lip/Palate syndrome (AEC).

Diagnosis[edit | edit source]

Diagnosis of Rapp–Hodgkin syndrome is based on clinical evaluation and the identification of characteristic features. Genetic testing can confirm the presence of mutations in the TP63 gene. Differential diagnosis includes other forms of ectodermal dysplasia and syndromes with overlapping features.

Management[edit | edit source]

Management of Rapp–Hodgkin syndrome is symptomatic and supportive. This may include:

Epidemiology[edit | edit source]

Rapp–Hodgkin syndrome is extremely rare, with only a few cases reported in the medical literature. The exact prevalence is unknown.

See also[edit | edit source]

References[edit | edit source]

External links[edit | edit source]

-


Contributors: Prab R. Tumpati, MD